Nimbus Discovery Announces Agreement With Shire plc (SHPG) to Co-Develop Therapies for Rare Diseases
5/8/2013 10:58:44 AM
More...
|
Nimbus Discovery Appoints William F. Westlin, Ph.D., as Head of Preclinical Research and Early Development
2/6/2013 9:31:28 AM
More...
|
Nimbus Discovery IRAK4 Inhibitors Demonstrate Synergistic Effects With BTK Inhibitor Ibrutinib
12/10/2012 10:02:01 AM
More...
|
Nimbus Discovery Presents Preclinical Data on Highly Selective IRAK4 Inhibitors for the Treatment of Rheumatic Diseases
11/12/2012 10:02:00 AM
More...
|
Nimbus Discovery and Proteros biostructures GmbH Enter into Privileged X-Ray Crystallography Partnership Agreement
11/8/2012 10:26:19 AM
More...
|
Nimbus Discovery Names Daniel S. Lynch Executive Chairman
11/1/2012 11:12:07 AM
More...
|
Nimbus Discovery Secures $24 Million Series A Financing
6/28/2011 7:11:32 AM
More...
|